2g20: Difference between revisions

No edit summary
No edit summary
Line 1: Line 1:
[[Image:2g20.gif|left|200px]]
{{Seed}}
[[Image:2g20.png|left|200px]]


<!--
<!--
Line 9: Line 10:
{{STRUCTURE_2g20|  PDB=2g20  |  SCENE=  }}  
{{STRUCTURE_2g20|  PDB=2g20  |  SCENE=  }}  


'''Ketopiperazine-Based Renin Inhibitors: Optimization of the C Ring'''
===Ketopiperazine-Based Renin Inhibitors: Optimization of the C Ring===




==Overview==
<!--
A systematic investigation of the S3 sub-pocket activity requirements was conducted. It was observed that linear and sterically small side chain substituents are preferred in the S3 sub-pocket for optimal renin inhibition. Polar groups in the S3-sub-pocket were not well tolerated and caused a reduction in renin inhibitory activity. Further, compounds with clog P's &lt; or = 3 demonstrated a dramatic reduction in CYP3A4 inhibitory activity.
The line below this paragraph, {{ABSTRACT_PUBMED_16480874}}, adds the Publication Abstract to the page
(as it appears on PubMed at http://www.pubmed.gov), where 16480874 is the PubMed ID number.
-->
{{ABSTRACT_PUBMED_16480874}}


==Disease==
==Disease==
Line 31: Line 35:
[[Category: Zhanga, E.]]
[[Category: Zhanga, E.]]
[[Category: Protein-ligand complex]]
[[Category: Protein-ligand complex]]
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May  4 04:36:14 2008''
 
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 06:14:08 2008''

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA